The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors

S. Cangoz, Y. Y. Chang, S. J. Chempakaseril, R. C. Guduru, L. M. Huynh, J. S. John, S. T. John, M. E. Joseph, R. Judge, R. Kimmey, K. Kudratov, P. J. Lee, I. C. Madhani, P. J. Shim, S. Singh, S. Singh, C. Ruchalski, R. B. Raffa

Research output: Contribution to journal › Review article › peer-review